NCT01258686View on ClinicalTrials.gov

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

August 31, 2013

Conditions
Hepatitis C
Interventions
DRUG

Silymarin

700mg thrice daily

DRUG

Placebo

Placebo 700mg thrice daily

Trial Locations (1)

Unknown

Byung Chul, Yoo, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT01258686 - Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy | Biotech Hunter | Biotech Hunter